Viewing Study NCT05797233


Ignite Creation Date: 2025-12-25 @ 3:01 AM
Ignite Modification Date: 2025-12-31 @ 4:00 AM
Study NCT ID: NCT05797233
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-08-19
First Post: 2023-04-01
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Trial of Anti-CD19 and Anti-CD20 Bicistronic Chimeric Antigen Receptor T Cells for Treating B-Cell Malignancies
Sponsor: National Cancer Institute (NCI)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module